Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #104223 on Quantum Materials Corp. (fka QTMM)
Kurt_Banoffee
12/22/23 10:41 PM
#104224 RE: drugmanrx #104223
shoondale
12/26/23 10:21 AM
#104226 RE: drugmanrx #104223
Our CFO and his staff re continuing to work to position the company to submit an S1 before the end of this year
12/26/23 10:24 AM
#104227 RE: drugmanrx #104223
"Courtesy of Jaythree"
12/26/23 10:29 AM
#104228 RE: drugmanrx #104223
"clinical trials before the end of 2023"
12/26/23 10:38 AM
#104229 RE: drugmanrx #104223
"will continue to be largely focused on the commercialization of our products until such a time sustainable revenues are achieved. Thank you again for your inquiry and your patience as we work to bring our disruptive technologies to market."
12/26/23 7:32 PM
#104230 RE: drugmanrx #104223
The third quarterly reports from Podesta Lobbying Group is out
dcmski
01/14/24 11:32 AM
#104244 RE: drugmanrx #104223
01/15/24 9:24 PM
#104245 RE: drugmanrx #104223
Our pre-submission has already been submitted to the FDA and we believe this test will be processed under the EUA.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads